Dr. Paplomata is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Madison
Madison, WI 53792- Is this information wrong?
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014
Texas Health Resources (Dallas)Residency, Internal Medicine, 2008 - 2011
Istanbul University FomClass of 2001
Certifications & Licensure
WI State Medical License 2019 - 2025
GA State Medical License 2013 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores Start of enrollment: 2009 Apr 01
- Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer Start of enrollment: 2009 May 01
- Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers Start of enrollment: 2009 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metas...G Curigliano, V Mueller, V Borges, E Hamilton, S Hurvitz, S Loi, R Murthy, A Okines, E Paplomata, D Cameron, L A Carey, K Gelmon, G N Hortobagyi, I Krop, S Loibl, M Pe...> ;Annals of Oncology. 2023 Jul 1
- 43 citationsTucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Bra...Nancy U Lin, Rashmi K Murthy, Vandana Abramson, Carey Anders, Thomas Bachelot, Philippe L Bedard, Virginia Borges, David Cameron, Lisa A Carey, A Jo Chien, Giuseppe Cu...> ;JAMA Oncology. 2023 Feb 1
- 81 citationsTucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB...G Curigliano, V Mueller, V Borges, E Hamilton, S Hurvitz, S Loi, R Murthy, A Okines, E Paplomata, D Cameron, L A Carey, K Gelmon, G N Hortobagyi, I Krop, S Loibl, M Pe...> ;Annals of Oncology. 2022 Mar 1
- Join now to see all
Journal Articles
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerRita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology
Authored Content
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast CancerJuly 2020
Press Mentions
At the Intersection of Breast and Gynecologic Cancers: Dr. Elisavet PaplomataMay 14th, 2020
mTOR Biology and the Growing Role for mTOR Inhibitors in the Management of Breast CancerMarch 27th, 2015
Professional Memberships
- Member
Other Languages
- Greek, Turkish, French
Hospital Affiliations
Grady Health SystemAtlanta, Georgia
University HospitalMadison, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
